Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2015 1
2017 2
2019 1
2020 2
2021 3
2022 4
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Breast cancer patient experiences through a journey map: A qualitative study.
Ciria-Suarez L, Jiménez-Fonseca P, Palacín-Lois M, Antoñanzas-Basa M, Fernández-Montes A, Manzano-Fernández A, Castelo B, Asensio-Martínez E, Hernando-Polo S, Calderon C. Ciria-Suarez L, et al. Among authors: hernando polo s. PLoS One. 2021 Sep 22;16(9):e0257680. doi: 10.1371/journal.pone.0257680. eCollection 2021. PLoS One. 2021. PMID: 34550996 Free PMC article.
Immunotherapy in Advanced Prostate Cancer: Current Knowledge and Future Directions.
López-Campos F, Gajate P, Romero-Laorden N, Zafra-Martín J, Juan M, Hernando Polo S, Conde Moreno A, Couñago F. López-Campos F, et al. Among authors: hernando polo s. Biomedicines. 2022 Feb 24;10(3):537. doi: 10.3390/biomedicines10030537. Biomedicines. 2022. PMID: 35327339 Free PMC article. Review.
Changing the History of Prostate Cancer with New Targeted Therapies.
Hernando Polo S, Moreno Muñoz D, Rosero Rodríguez AC, Silva Ruiz J, Rosero Rodríguez DI, Couñago F. Hernando Polo S, et al. Biomedicines. 2021 Apr 6;9(4):392. doi: 10.3390/biomedicines9040392. Biomedicines. 2021. PMID: 33917592 Free PMC article. Review.
Clinical Factors Associated With Long-Term Benefit in Patients With Metastatic Renal Cell Carcinoma Treated With Axitinib: Real-World AXILONG Study.
Pinto Á, Reig O, Iglesias C, Gallardo E, García-Del Muro X, Alonso T, Anguera G, Suárez C, Muñoz-Langa J, Villalobos-León L, Rodríguez-Sánchez Á, Lainez N, Martínez-Ortega E, Campayo M, Velastegui A, Rodriguez-Vida A, Villa-Guzmán JC, Méndez-Vidal MJ, Rubio G, García I, Capdevila L, Lambea J, Vázquez S, Fernández O, Hernando-Polo S, Cerezo S, Santander C, García-Marrero R, Zambrana F, González-Del Alba A, Lazaro-Quintela M, Castellano D, Chirivella I, Anido U, Viana A, García A, Sotelo M, Arévalo MG, García-Donas J, Hernández C, Bolós MV, Llinares J, Climent MA. Pinto Á, et al. Among authors: hernando polo s. Clin Genitourin Cancer. 2022 Feb;20(1):25-34. doi: 10.1016/j.clgc.2021.09.006. Epub 2021 Oct 20. Clin Genitourin Cancer. 2022. PMID: 34789409
Psychological distress and resilience in patients with advanced cancer during the Covid-19 pandemic: the mediating role of spirituality.
Mihic-Gongora L, Jiménez-Fonseca P, Hernandez R, Gil-Raga M, Pacheco-Barcia V, Manzano-Fernández A, Hernando-Polo S, Antoñanzas-Basa M, Corral MJ, Valero-Arbizu M, Calderon C. Mihic-Gongora L, et al. Among authors: hernando polo s. BMC Palliat Care. 2022 Aug 13;21(1):146. doi: 10.1186/s12904-022-01034-y. BMC Palliat Care. 2022. PMID: 35962385 Free PMC article.
Ascertaining breast cancer patient experiences through a journey map: A qualitative study protocol.
Ciria-Suarez L, Jiménez-Fonseca P, Palacín-Lois M, Antoñanzas-Basa M, Férnández-Montes A, Manzano-Fernández A, Castelo B, Asensio-Martínez E, Hernando-Polo S, Calderon C. Ciria-Suarez L, et al. Among authors: hernando polo s. PLoS One. 2020 Dec 21;15(12):e0244355. doi: 10.1371/journal.pone.0244355. eCollection 2020. PLoS One. 2020. PMID: 33347475 Free PMC article. Updated.
Long-term Clinical Outcomes of a Spanish Cohort of Metastatic Renal Cell Carcinoma Patients with a Complete Response to Sunitinib.
de Velasco G, Alonso-Gordoa T, Rodríguez-Vida A, Anguera G, Campayo M, Pinto Á, Ortega EM, Gallardo E, Núñez NF, García-Carbonero I, Reig O, Méndez-Vidal MJ, Fernández-Calvo O, Cassinello NV, Torregrosa D, López-Martín A, Rosero A, Valiente PG, de España CG, Climent MA, Santasusana MD, Sánchez ÁR, González IC, Afonso R, García Del Muro X, Casinello J, Fernández-Parra EM, García Sánchez L, Afonso J, Polo SH, Asensio Ú. de Velasco G, et al. Among authors: polo sh. Clin Genitourin Cancer. 2023 Jun;21(3):e166-e174. doi: 10.1016/j.clgc.2022.11.021. Epub 2022 Dec 5. Clin Genitourin Cancer. 2023. PMID: 36610891
Mammographic density and breast cancer in women from high risk families.
Ramón Y Cajal T, Chirivella I, Miranda J, Teule A, Izquierdo Á, Balmaña J, Sánchez-Heras AB, Llort G, Fisas D, Lope V, Hernández-Agudo E, Juan-Fita MJ, Tena I, Robles L, Guillén-Ponce C, Pérez-Segura P, Luque-Molina MS, Hernando-Polo S, Salinas M, Brunet J, Salas-Trejo MD, Barnadas A, Pollán M. Ramón Y Cajal T, et al. Among authors: hernando polo s. Breast Cancer Res. 2015 Jul 11;17(1):93. doi: 10.1186/s13058-015-0604-1. Breast Cancer Res. 2015. PMID: 26163143 Free PMC article.
Final Overall Survival Analysis of the SOGUG Phase 2 MAJA Study: Maintenance Vinflunine Versus Best Supportive Care After First-Line Chemotherapy in Advanced Urothelial Carcinoma.
Bellmunt Molins J, García-Donas Jiménez J, Valderrama BP, Virizuela Echaburu JA, Hernando-Polo S, Climent Durán MÁ, Villa-Guzmán JC, Arranz Arija JÁ, Ostiategui ML, Milagro NL, González-Del-Alba A, González BM, Díaz EG, Gauna DC, Santasusana MD, Herranz UA, Del Muro Solans XG, Pérez-Gracia JL, Vázquez JP, Morales-Barrera R, Pous AF. Bellmunt Molins J, et al. Among authors: hernando polo s. Clin Genitourin Cancer. 2020 Dec;18(6):452-460. doi: 10.1016/j.clgc.2020.05.004. Epub 2020 May 11. Clin Genitourin Cancer. 2020. PMID: 32565133 Clinical Trial.
Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial.
Vergote I, Scambia G, O'Malley DM, Van Calster B, Park SY, Del Campo JM, Meier W, Bamias A, Colombo N, Wenham RM, Covens A, Marth C, Raza Mirza M, Kroep JR, Ma H, Pickett CA, Monk BJ; TRINOVA-3/ENGOT-ov2/GOG-3001 investigators. Vergote I, et al. Lancet Oncol. 2019 Jun;20(6):862-876. doi: 10.1016/S1470-2045(19)30178-0. Epub 2019 May 7. Lancet Oncol. 2019. PMID: 31076365 Free article. Clinical Trial.
13 results